

소개
Metformin has recently emerged as a promising biologically active molecule in endodontics with potential use as an intracanal medicament. Beyond its systemic glucose-lowering effect, metformin activates the AMPK pathway, leading to modulation of inflammation, reduction of pro-inflammatory cytokines such as IL-6 and TNF-α, and inhibition of osteoclast-mediated bone resorption.



